Our research focuses on designing molecular probes to specifically target cancer-relevant facilitative sugar transporters – GLUTs and developing biochemical assay for identifying and understanding links between impaired biological mechanisms and cancer. We heavily rely on chemical biology to understand molecular interactions that control cellular equilibrium and use synthetic organic chemistry to produce small molecules to monitor and adjust impaired biochemical processes.